For 5 weeks, the tiny Impella kept Katrina Penney's failed heart pumping while a second heart transplant was secured.

Even though the FDA referred to a recall, the device will remain on the market. The New York Times first reported details of the Impella pump. Johnson & Johnson MedTech acquired Abiomed in 2022.

In June 2023, Abiomed issued an urgent medical device correction for its Impella 2.5 intravascular micro axial blood pump, which supports the heart. In patients with a certain type of replacement ...

She said the Abiomed will "is a high ... $1 billion-plus annual sales from its Impella range of heart pumps, which are billed as the smallest such devices available in the world and have enjoyed ...

The goal of the trial was to evaluate treatment with an Impella percutaneous left ventricular assist device (LVAD) compared with an intra-aortic balloon pump (IABP) in patients with cardiogenic ...